LOGO
LOGO

Quick Facts

Co-Diagnostics Stock Climbs 32% Over Commercial Expansion Agreement With CoSara Diagnostics

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News

Shares of Co-Diagnostics, Inc. (CODX) are gaining about 32 percent on Friday morning trading over its agreement with CoSara Diagnostics Pvt. Ltd. to significantly expand its commercial and distribution territory across South Asia to now include Bangladesh, Pakistan, Nepal, and Sri Lanka.

The company's shares are currently trading at $3.52 on the Nasdaq, up 32.83 percent. The stock opened at $3.86 and has climbed as high as $3.95 so far in today's session. Over the past year, it has traded in a range of $2.05 to $46.5.

The expansion reflects the company's broader strategy of establishing regional infrastructure ahead of product commercialization.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.
Global Economics Weekly Update - May 04 – May 08, 2026

May 08, 2026 15:50 ET
Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.

Latest Updates on COVID-19